• Opinion
• [Reporter's view] Fight between AZ/Janssen
• by Jung, Sae-Im Aug 17, 2023 05:29am

• Policy
• ₩176.5 bil was spent on atopic dermatitis every year
• by Kim, Jung-Ju Aug 16, 2023 05:37am

• Policy
• Will it be possible to cover 'obesity drugs'?
• by Lee, Jeong-Hwan Aug 16, 2023 05:37am

• Company
• Companies seek to invalidate Jardiance’s unlisted patents
• by Kim, Jin-Gu Aug 16, 2023 05:37am

• Company
• [Reporter’s View] Trending CSO sales and their treatment
• by Lee, Seok-Jun Aug 16, 2023 05:37am

• Company
• Cinqair draws attention to entry into reimbursement rights
• by Eo, Yun-Ho Aug 16, 2023 05:37am

• Company
• the era of Lung cancer cure
• by Jung, Sae-Im Aug 14, 2023 05:21am

• Company
• First immuno-oncology drug for endometrial cancer?
• by Eo, Yun-Ho Aug 14, 2023 05:21am

• Company
• With the BPH drug Duodart be the first combo to succeed?
• by Kim, Jin-Gu Aug 14, 2023 05:21am

• Company
• Oral SMA drug Evrysdi prescribed at tertiary hospitals
• by Eo, Yun-Ho Aug 14, 2023 05:21am